Fulminant myocarditis following SARS-CoV-2 mRNA vaccination rescued with venoarterial ECMO: A report of two cases.

Rosa Vila-Olives,Aitor Uribarri,María Martínez-Martínez,Eduard Argudo,Camilo Bonilla,Luis Chiscano,Lorena Herrador,Alejandra Gabaldón, Irene Buera, Maria Vidal, Ana De la Iglesia, Maria Ángeles Díaz, Elena López, Marta Font, Jose A Barrabés,Jordi Riera, Ignacio Ferreira-González,Ricard Ferrer

Perfusion（2023）

引用 2|浏览11

暂无评分

摘要

COVID-19 vaccine-associated fulminant myocarditis has a high morbidity and mortality but presents a high potential for recovery. V-A ECMO should be established in cases with refractory cardiogenic shock during the acute phase.

查看译文

关键词

COVID-19 vaccine,Cardiogenic shock,SARS-CoV2,fulminant myocarditis,mRNA vaccine,mechanical support,venoarterial ECMO

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要